Health

Results: 4369-4380 of 7366

Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England

Parse Biosciences Partners with Taiwan-based Prisma Biotech to Extend Reach in Asia

PR Newswire associated0

Endo to Host Investor Call on Second Quarter 2024 Financial Results

PR Newswire associated0

PeproMene Bio announced study demonstrating strong polyfunctionality of novel chimeric antigen receptor (CAR) T cells

PR Newswire associated0

Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices

Alnylam to Present Detailed Results from the HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress 2024

PR Newswire associated0

AI that Detects Hidden Heart Disease is a Finalist for British Heart Foundation's 'Research Project of the Year' Award

Takeda Receives European Commission Approval for ADZYNMA®▼ (Recombinant ADAMTS13) as the First and Only Recombinant ADAMTS13 Replacement Therapy for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

(Graphic: Business Wire)

BeiGene Enters Next Phase of Global Growth with Announcement of Second Quarter 2024 Financial Results and Corporate Updates

Kyowa Kirin International and NewBridge Pharmaceuticals Enter Into Agreement to Improve Access to Medicines for Rare Disease Patients Across Middle East and North Africa

MindMed to Present at Canaccord Genuity’s 44th Annual Growth Conference

Bulletin from the extraordinary general meeting of Enzymatica AB (publ) on 6 August 2024